Daclizumab Subcutaneous and Oxycodone Concentrate
Determining the interaction of Daclizumab Subcutaneous and Oxycodone Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: oxycodone
Brand name: Oxaydo, Oxycontin, Oxyfast, Roxicodone, Roxybond, Xtampza ER; oxycodone is also present in the following combination drugs: Combunox, Endocet, Endodan, Moxduo, Oxycodan, Percocet, Percodan, Primlev, Roxicet, Xartemis XR, and others, Oxycontin, Xtampza ER, Oxecta, OxyIR, Roxybond
Synonyms: Oxycodone, OxyCODONE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Oxycodone ER
- Daclizumab Subcutaneous-Oxycodone Extended-Release Capsules
- Daclizumab Subcutaneous-Oxycodone Extended-Release Tablets
- Daclizumab Subcutaneous-Oxycodone Hydrochloride
- Daclizumab Subcutaneous-Oxycodone Immediate-Release Capsules
- Daclizumab Subcutaneous-Oxycodone Solution
- Oxycodone Concentrate-Dacogen
- Oxycodone Concentrate-Dacomitinib
- Oxycodone Concentrate-Dactinomycin
- Oxycodone Concentrate-Dactinomycin Injection
- Oxycodone Concentrate-Dactinomycin Intravenous
- Oxycodone Concentrate-Daklinza